Theratechnologies Price/Book
What is the Price/Book of Theratechnologies?
The Price/Book of Theratechnologies Inc. is 7.84
What is the definition of Price/Book?
Price to book ratio represents the ratio between a company’s stock value and the book value per share.
mrq (most recent quarter)
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book of companies in the Health Care sector on NASDAQ compared to Theratechnologies
What does Theratechnologies do?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Companies with price/book similar to Theratechnologies
- Eminent Gold has Price/Book of 7.83
- Compania de Distribucion Integral Logista S.A has Price/Book of 7.83
- SML Isuzu has Price/Book of 7.83
- Varian Medical Systems has Price/Book of 7.84
- Eagle Mountain Mining has Price/Book of 7.84
- Wisetech Global has Price/Book of 7.84
- Theratechnologies has Price/Book of 7.84
- Gran Tierra has Price/Book of 7.84
- China Baofeng (International) has Price/Book of 7.84
- Koolearn Technology has Price/Book of 7.84
- eXp World Inc has Price/Book of 7.85
- Firstsource Solutions has Price/Book of 7.85
- Rimbaco Grp Global Ltd has Price/Book of 7.85